Primary Category:
Treatment Protocols
Disease Category:
Colon, Gastrointestinal
Status:
New, Open
Randomized Trial of Consolidation Targeted Adjuvant Therapy with Encorafenib and Cetuximab Versus Usual Care for Patients with Stage II/III BRAF V600E Colon Cancer
NCT#05710406
